Sponsor Pipeline

Inozyme Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
2
Recruiting
2
Phase 3
6
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT07473973
ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1…		 Enrollment closed, study ongoing
2026-08-11 NCT07473973
ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1…		 date change Primary completion moved earlier: 2028-09-11 -> 2026-10-14
2026-08-11 NCT07473973
ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1…		 date change Completion moved earlier: 2028-11-07 -> 2026-10-14
2026-08-11 NCT05734196
The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1…		 Enrollment closed, study ongoing
2026-08-11 NCT05734196
The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1…		 date change Primary completion moved earlier: 2027-11-11 -> 2026-10-14
2026-08-11 NCT05734196
The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1…		 date change Completion moved earlier: 2027-11-11 -> 2026-10-14
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-04 NCT07745179 Natural History Study: ENPP1 Deficiency or the Early-Onset Form of ABCC6 Deficiency Completed
Active Trials by Phase
Phase 3
2
Phase 2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06046820 The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1… Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency Active, Not Recruiting
NCT07473973 ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1… Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency Active, Not Recruiting
Phase 2
NCT06462547 ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and… Gene Mutations Recruiting
Phase 1
NCT05734196 The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1… Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency Active, Not Recruiting
Not specified
NCT06302439 PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6… Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency Recruiting
Get alerts when Inozyme Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free